EGFR and non-small cell lung carcinoma: The sensitivity of EGFR exon 19-insertions (exon 19ins) to EGFR-TKIs is unclear, given that these mutations have been observed in only 0.26% and 0.11% of large Caucasian and Asian cohorts of EGFRM+ NSCLC patients, respectively [97,98].